Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Current Leases: 2010-2024

Historic Current Leases for Madrigal Pharmaceuticals (MDGL) over the last 11 years, with Dec 2024 value amounting to $983,000.

  • Madrigal Pharmaceuticals' Current Leases rose 23.35% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 23.35%. This contributed to the annual value of $983,000 for FY2024, which is 86.53% up from last year.
  • Madrigal Pharmaceuticals' Current Leases amounted to $983,000 in FY2024, which was up 86.53% from $527,000 recorded in FY2023.
  • Over the past 5 years, Madrigal Pharmaceuticals' Current Leases peaked at $983,000 during FY2024, and registered a low of $318,000 during FY2020.
  • Its 3-year average for Current Leases is $704,000, with a median of $602,000 in 2022.
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Current Leases fell by 12.46% in 2023 and then skyrocketed by 86.53% in 2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' Current Leases (Yearly) stood at $318,000 in 2020, then increased by 28.93% to $410,000 in 2021, then skyrocketed by 46.83% to $602,000 in 2022, then decreased by 12.46% to $527,000 in 2023, then spiked by 86.53% to $983,000 in 2024.